Stiripentol
Who holds supplier records for Stiripentol? 5 organisations hold a current record for Stiripentol: an active US FDA Type II Drug Master File. Recorded organisation countries for current records: India (4); not recorded for 1.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Stiripentol: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/stiripentol
Reading the evidence
- 5 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
4 of the 4 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 2 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (5)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Stiripentol. Country is the organisation's recorded country, not necessarily the manufacturing site.
- ALP PHARM BEIJING CO LTDActive DMF 35817 · latest filing Apr 2021
- METROCHEM API PRIVATE LTDIndiaActive DMF 38097 · latest filing Mar 2023
- MSN LIFE SCIENCES PRIVATE LIMITEDIndia Company GMP cert on recordActive DMF 34328 · latest filing Nov 2019
- SS PHARMA LLCIndiaActive DMF 33252 · latest filing Mar 2019
- Torrent PharmaceuticalsIndia Company GMP cert on recordActive DMF 39256 · latest filing Dec 2023
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
US product patents and exclusivity
The FDA Orange Book lists patents and exclusivities for specific approved products (4 listed products contain Stiripentol). The latest listed exclusivity runs to 14 Jul 2029. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.
Overview
Stiripentol is an anticonvulsant medication used to treat seizures in individuals with Dravet syndrome, a severe form of epilepsy. It works by stabilizing neuronal activity and has been shown to enhance the effect of other antiepileptic drugs.
Chemical identity
- IUPAC name
- (E)-1-(1,3-benzodioxol-5-yl)-4,4-dimethylpent-1-en-3-ol
- Canonical SMILES
- CC(C)(C)C(/C=C/C1=CC2=C(C=C1)OCO2)O
- InChIKey
- IBLNKMRFIPWSOY-FNORWQNLSA-N
- Synonyms
- Diacomit API, bcx 2600, bcx-2600, diacomit
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Stiripentol?
5 organisations hold an active US FDA Type II Drug Master File or a CEP for Stiripentol: ALP PHARM BEIJING CO LTD, METROCHEM API PRIVATE LTD (India), MSN LIFE SCIENCES PRIVATE LIMITED (India), SS PHARMA LLC (India) and Torrent Pharmaceuticals (India). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Stiripentol Drug Master Files are active?
ALP PHARM BEIJING CO LTD (DMF 35817), METROCHEM API PRIVATE LTD (DMF 38097), MSN LIFE SCIENCES PRIVATE LIMITED (DMF 34328), SS PHARMA LLC (DMF 33252) and Torrent Pharmaceuticals (DMF 39256). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
How do I qualify a Stiripentol supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Stiripentol?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.